Lertal®, a multicomponent nutraceutical, could reduce the use of antihistamines in children with allergic rhinoconjunctivitis.
Journal
Acta bio-medica : Atenei Parmensis
ISSN: 2531-6745
Titre abrégé: Acta Biomed
Pays: Italy
ID NLM: 101295064
Informations de publication
Date de publication:
11 May 2020
11 May 2020
Historique:
received:
06
05
2020
entrez:
19
5
2020
pubmed:
19
5
2020
medline:
30
3
2021
Statut:
epublish
Résumé
Antihistamines are the cornerstone treatment of allergic rhinitis (AR). To quantify the antihistaminic consume is particularly relevant in clinical practice, since a remarkable use is usually associated with severe symptoms. The aim of the study was to measure the use of antihistamines in two groups of children suffering from AR. The first group took a course of a nutraceutical (Lertal®) before the observation (active group, AG); a second one was considered as control (control group, CG). Both groups took antihistamines on demand. The children were visited at baseline and after 1 year. The number of days of antihistaminic use was the primary outcome. Children in AG had a significant reduced number of antihistamines use in comparison with CG (p=0.008). In conclusion, the current study showed that a course with a multicomponent nutraceutical could reduce the use of symptomatic antihistamines in children with allergic rhinoconjuncti- vitis.
Identifiants
pubmed: 32420973
doi: 10.23750/abm.v91i2.9719
pmc: PMC7569653
doi:
Substances chimiques
Histamine Antagonists
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
356-359Références
Int Rev Immunol. 2017 Jan 2;36(1):41-53
pubmed: 28102718
J Allergy Clin Immunol. 2017 Oct;140(4):950-958
pubmed: 28602936
Evid Based Complement Alternat Med. 2013;2013:925342
pubmed: 24319488
Ital J Pediatr. 2019 Jul 18;45(1):84
pubmed: 31319883
Molecules. 2016 May 12;21(5):
pubmed: 27187333
Ann Allergy Asthma Immunol. 2001 Sep;87(3):222-6
pubmed: 11570619
Clin Exp Allergy. 1997 Feb;27(2):182-91
pubmed: 9061218
Allergy. 2018 Jan;73(1):37-49
pubmed: 28675776
Pediatr Allergy Immunol. 2016 Sep;27(6):580-90
pubmed: 27188226
Acta Biomed. 2019 Jul 03;90(7-S):41-44
pubmed: 31292426
Allergy. 2011 May;66(5):629-36
pubmed: 21261656
J Biol Regul Homeost Agents. 2019 Apr 10;33(2):617-622
pubmed: 30968678
Ann Allergy Asthma Immunol. 2005 Feb;94(2):258-61
pubmed: 15765742
Inflamm Allergy Drug Targets. 2010 Sep;9(4):263-85
pubmed: 20887269
Expert Rev Clin Immunol. 2014 Oct;10(10):1309-24
pubmed: 25205329
Front Immunol. 2019 May 29;10:821
pubmed: 31191511
Ann Intern Med. 2017 Dec 19;167(12):876-881
pubmed: 29181536
Food Chem Toxicol. 2017 Oct;108(Pt B):375-391
pubmed: 27890564
Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352
pubmed: 29438602
Int Arch Allergy Immunol. 2004 May;134(1):34-40
pubmed: 15051938
Allergy. 2001 Nov;56(11):1068-70
pubmed: 11703220
Clin Exp Allergy. 1995 Sep;25(9):871-8
pubmed: 8564726